Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Anemia

  Free Subscription


03.10.2017

4 Am J Hematol
1 Blood
2 Exp Hematol
12 J Pediatr Hematol Oncol
7 Lancet Haematol
1 Leukemia
1 Nephrol Dial Transplant
4 PLoS One
1 Transfusion


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Hematol

  1. SUN CW, Wu LC, Knopick PL, Bradley DS, et al
    Sickle cells produce functional immune modulators and cytotoxics.
    Am J Hematol. 2017;92:981-988.
    PubMed     Text format     Abstract available

  2. WITZIG TE, Zinzani PL, Habermann TM, Tuscano JM, et al
    Long-Term Analysis of Phase II Studies of Single-Agent Lenalidomide in Relapsed/Refractory Mantle Cell Lymphoma.
    Am J Hematol. 2017 Jul 11. doi: 10.1002/ajh.24854.
    PubMed     Text format     Abstract available

  3. VAN TUIJN CFJ, Schimmel M, van Beers EJ, Nur E, et al
    Prospective evaluation of chronic organ damage in adult sickle cell patients: A seven-year follow-up study.
    Am J Hematol. 2017;92:E584-E590.
    PubMed     Text format     Abstract available

  4. CAPPELLINI MD, Comin-Colet J, de Francisco A, Dignass A, et al
    Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management.
    Am J Hematol. 2017;92:1068-1078.
    PubMed     Text format     Abstract available


    Blood

  5. GANZ T, Jung G, Naeim A, Ginzburg Y, et al
    Immunoassay for human serum erythroferrone.
    Blood. 2017;130:1243-1246.
    PubMed     Text format     Abstract available


    Exp Hematol

  6. ZHAO X, Feng X, Wu Z, Winkler T, et al
    Persistent elevation of plasma thrombopoietin levels after treatment in severe aplastic anemia.
    Exp Hematol. 2017 Sep 20. pii: S0301-472X(17)30775.
    PubMed     Text format     Abstract available

  7. JAGADEESWARAN R, Vazquez BA, Thiruppathi M, Ganesh BB, et al
    Pharmacological inhibition of LSD1 and mTOR reduces mitochondrial retention and associated ROS levels in the red blood cells of sickle cell disease.
    Exp Hematol. 2017;50:46-52.
    PubMed     Text format     Abstract available


    J Pediatr Hematol Oncol

  8. TUFEKCI O, Atabay B, Turker M, Yilmaz Bengoa S, et al
    Evaluation of the Clinical and Laboratory Characteristics of Previously Followed-up Thalassemia Intermedia Patients to Provide Them Better Care in the Future.
    J Pediatr Hematol Oncol. 2017;39:440-444.
    PubMed     Text format     Abstract available

  9. MANTADAKIS E, Farmaki E
    Natural History, Pathogenesis, and Treatment of Evans Syndrome in Children.
    J Pediatr Hematol Oncol. 2017;39:413-419.
    PubMed     Text format     Abstract available

  10. NAVALKELE P, Ozgonenel B, McGrath E, Lephart P, et al
    Invasive Pneumococcal Disease in Patients With Sickle Cell Disease.
    J Pediatr Hematol Oncol. 2017;39:341-344.
    PubMed     Text format     Abstract available

  11. ACQUAZZINO MA, Miller M, Myrvik M, Newby R, et al
    Attention Deficit Hyperactivity Disorder in Children With Sickle Cell Disease Referred for an Evaluation.
    J Pediatr Hematol Oncol. 2017;39:350-354.
    PubMed     Text format     Abstract available

  12. INGERSKI LM, Arnold TL, Banks G, Porter JS, et al
    Clinic Attendance of Youth With Sickle Cell Disease on Hydroxyurea Treatment.
    J Pediatr Hematol Oncol. 2017;39:345-349.
    PubMed     Text format     Abstract available

  13. JASINSKI S, Weinblatt ME, Glasser CL
    Sirolimus as an Effective Agent in the Treatment of Immune Thrombocytopenia (ITP) and Evans Syndrome (ES): A Single Institution's Experience.
    J Pediatr Hematol Oncol. 2017;39:420-424.
    PubMed     Text format     Abstract available

  14. OLIVEIRA MI, Batalha S, Gouveia C, Maia R, et al
    Pantoea Species Bacteremia in a Child With Sickle Cell Disease: Looking for a Culprit.
    J Pediatr Hematol Oncol. 2017;39:e307-e308.
    PubMed     Text format     Abstract available

  15. HASHEM H, Egler R, Dalal J
    Refractory Pure Red Cell Aplasia Manifesting as Deficiency of Adenosine Deaminase 2.
    J Pediatr Hematol Oncol. 2017;39:e293-e296.
    PubMed     Text format     Abstract available

  16. TUYSUZ G, Tayfun F
    Health-related Quality of Life and its Predictors Among Transfusion-dependent Thalassemia Patients.
    J Pediatr Hematol Oncol. 2017;39:332-336.
    PubMed     Text format     Abstract available

  17. HASHEMIEH M, Radfar M, Azarkeivan A, Noghabaei G, et al
    T2* Magnetic Resonance Imaging Study of Pancreatic Iron Overload and its Relation With the Diabetic State in Thalassemic Patients.
    J Pediatr Hematol Oncol. 2017;39:337-340.
    PubMed     Text format     Abstract available

  18. ADEKILE AD, Akbulut N, Azab AF, Al-Sharida S, et al
    The Sickle beta-Thalassemia Phenotype.
    J Pediatr Hematol Oncol. 2017;39:327-331.
    PubMed     Text format     Abstract available

  19. OZ S, Kupeli S, Sezgin G, Bayram I, et al
    Thalassemia Major and Priapism: A Case Report of an Adolescent.
    J Pediatr Hematol Oncol. 2017;39:e336-e337.
    PubMed     Text format     Abstract available


    Lancet Haematol

  20. HEUBERGER JAAC, Rotmans JI, Gal P, Stuurman FE, et al
    Erythropoietin on cycling performance - Authors' reply.
    Lancet Haematol. 2017;4:e462-e464.
    PubMed     Text format    

  21. BEJDER J, Nybo L, Sawka MN, Joyner MJ, et al
    Erythropoietin on cycling performance.
    Lancet Haematol. 2017;4:e459-e460.
    PubMed     Text format    

  22. FAGUNDES NJR, Boquett J, Vianna FSL
    Erythropoietin on cycling performance.
    Lancet Haematol. 2017;4:e459.
    PubMed     Text format    

  23. LUNDBY C, Montero D
    Erythropoietin on cycling performance.
    Lancet Haematol. 2017;4:e460-e461.
    PubMed     Text format    

  24. VAN BREDA E, Truijen S
    Erythropoietin on cycling performance.
    Lancet Haematol. 2017;4:e460.
    PubMed     Text format    

  25. KAPPELLE LJW, van Rijt WG
    Erythropoietin on cycling performance.
    Lancet Haematol. 2017;4:e461-e462.
    PubMed     Text format    

  26. SPERLICH B, Calbet JAL, Holmberg HC
    Erythropoietin on cycling performance.
    Lancet Haematol. 2017;4:e462.
    PubMed     Text format    


    Leukemia

  27. ROSS DM
    Responses to pomalidomide and placebo in myelofibrosis-related anaemia.
    Leukemia. 2017;31:532-533.
    PubMed     Text format    


    Nephrol Dial Transplant

  28. VAN DEN BRAND JA, Verhave JC, Adang EM, Wetzels JF, et al
    Cost-effectiveness of eculizumab treatment after kidney transplantation in patients with atypical haemolytic uraemic syndrome.
    Nephrol Dial Transplant. 2017;32.
    PubMed     Text format     Abstract available


    PLoS One

  29. GREENWOOD S, Deane C, Rees OL, Freedman B, et al
    The significance of inadequate transcranial Doppler studies in children with sickle cell disease.
    PLoS One. 2017;12:e0181681.
    PubMed     Text format     Abstract available

  30. KEITA ALASSANE S, Nicolau-Travers ML, Menard S, Andreoletti O, et al
    Young Sprague Dawley rats infected by Plasmodium berghei: A relevant experimental model to study cerebral malaria.
    PLoS One. 2017;12:e0181300.
    PubMed     Text format     Abstract available

  31. BAKSHI N, Sinha CB, Ross D, Khemani K, et al
    Proponent or collaborative: Physician perspectives and approaches to disease modifying therapies in sickle cell disease.
    PLoS One. 2017;12:e0178413.
    PubMed     Text format     Abstract available

  32. JANG TY, Lin PC, Huang CI, Liao YM, et al
    Seroprevalence and clinical characteristics of viral hepatitis in transfusion-dependent thalassemia and hemophilia patients.
    PLoS One. 2017;12:e0178883.
    PubMed     Text format     Abstract available


    Transfusion

  33. KISS JE, Birch RJ, Steele WR, Wright DJ, et al
    Quantification of body iron and iron absorption in the REDS-II Donor Iron Status Evaluation (RISE) study.
    Transfusion. 2017;57:1656-1664.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: